Back

Telo Genomics reports clinical research supporting telomere platform for multiple myeloma relapse prediction

Verifying
  • Telo Genomics announced clinical research results involving its telomere analysis platform.
  • The results addressed the platform’s utility in predicting multiple myeloma relapse.
  • Multiple myeloma relapse prediction was the focus of the announced research.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.